NVCHI
BIIB icon

New Vernon Capital Holdings II’s Biogen BIIB Stock Holding History

New Vernon Capital Holdings II’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-733
Closed -$221K – 21
2018
Q4 		$221K Buy
733
+151
+26% +$48.2K 0.34% 37
2018
Q3 		$206K Buy
+582
New +$200K 0.21% 45

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

New Vernon Capital Holdings II's BIIB Position: Q1 2019 in Review

New Vernon Capital Holdings II sold out of Biogen (BIIB) in Q1 2019, closing a stake of 733 shares — an estimated $221K sold.

New Vernon Capital Holdings II first reported a position in BIIB in Q3 2018 and held it in 2 quarters. The position peaked at $221K in Q4 2018. 1,085 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

  • New Vernon Capital Holdings II reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
  • New Vernon Capital Holdings II sold 733 Biogen shares in Q1 2019, an estimated $221K.
  • New Vernon Capital Holdings II first reported a position in Biogen in Q3 2018 and held it in 2 quarters.
  • New Vernon Capital Holdings II's Biogen position peaked at $221K in Q4 2018.
  • 1,085 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on New Vernon Capital Holdings II's 13F filing for Q1 2019, filed 13 May 2019.